Spotlight

NovellusDX: Jerusalem-Based Personalized Medicine Company

LaunchPad Video March 31, 2017

Fusion Genomics – ONETest: the multiplex DNA/RNA NGS-based MDx platform for infectious diseases

LaunchPad Video March 31, 2017

IR2Dx – Precision Treatment Guidance For Diabetes

LaunchPad Video March 31, 2017

Vium – The Industry’s First Digital Vivarium

LaunchPad Video March 30, 2017

Ubiquigent – the keys to unlock the nascent value of ubiquitin system drug discovery

LaunchPad Video March 29, 2017

12 3 Page 1 of 3

Events

WuXi Global Forum 2017 Recap

May 17, 2017

Spotlight

Correlia Biosystems, creating next generation proteomic technology

May 17, 2017

Spotlight

AltheaDX, molecular diagnostics company specializing in the field of pharmacogenetics

May 17, 2017

Spotlight

GMI, developing new treatments and diagnostics for chronic health conditions

May 17, 2017

Spotlight

PlantForm Corp., low cost production of plant-made pharmaceuticals

May 17, 2017

STAY CONNECTED

WUXI NEWS

WuXi News

WuXi NextCODE Completes $240 Million Series B Financing

September 7, 2017

We are pleased to announce that WuXi NextCODE has successfully completed a $240 million Series B financing. The company extended and completed the Series...

The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics CGMP...

August 5, 2017

WuXi’s Pharmaceutical Development Services Division Merges with STA

July 31, 2017

STA Signs Supply Agreement with TESARO

July 25, 2017

WuXi NextCODE Completes $240 Million Series B Financing

The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics CGMP…

WuXi’s Pharmaceutical Development Services Division Merges with STA

STA Signs Supply Agreement with TESARO

China Market Authorization Holder System Summit 2017 Recap

Marketing Authorization Holder System Summit

WuXi Global Forum 2017 Recap

ChinaBio® Partnering Forum 20

WuXi Executive Luncheon at MIXiii BIOMED 2017

BIO 2017: Disease-Focused Foundations: An Increasing Influence in Drug Discovery and…

LaunchPad

Mensia Technologies: Digital Brain Therapies for ADHD Children

Flow Pharma: Programmable Vaccine Delivery

Precision NanoSystems – Creating Transformative Medicines

Biosignatures: A systematic, process based approach to diagnostic discovery

NovellusDX: Jerusalem-Based Personalized Medicine Company

Fusion Genomics – ONETest: the multiplex DNA/RNA NGS-based MDx platform for infectious diseases

IR2Dx – Precision Treatment Guidance For Diabetes

Vium – The Industry’s First Digital Vivarium

Ubiquigent – the keys to unlock the nascent value of ubiquitin system drug discovery

SPOTLIGHT

WuXi Global Forum 2017 Recap

Correlia Biosystems, creating next generation proteomic technology

AltheaDX, molecular diagnostics company specializing in the field of pharmacogenetics

GMI, developing new treatments and diagnostics for chronic health conditions

PlantForm Corp., low cost production of plant-made pharmaceuticals

STAY CONNECTED

WUXI NEWS

WuXi NextCODE Completes $240 Million Series B Financing

The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics CGMP...

WuXi’s Pharmaceutical Development Services Division Merges with STA

STA Signs Supply Agreement with TESARO

POPULAR POSTS

WuXi Global Forum 2014

BIO 2017: Disease-Focused Foundations: An Increasing Influence in Drug Discovery and...

FDA Grants Edaravone Orphan Drug Designation for Treatment of Amyotrophic Lateral...

POPULAR CATEGORY